{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:31:09Z","timestamp":1769473869485,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04332-y","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T12:03:58Z","timestamp":1766318638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the survival benefit of adjuvant chemotherapy based on tumor deposit status in stage II colon cancer patients from SEER database"],"prefix":"10.1007","volume":"17","author":[{"given":"Jiabin","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongrong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"4332_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","volume":"1","author":"C Fitzmaurice","year":"2015","unstructured":"Fitzmaurice C, Dicker D, Pain A, Hamavid H, et al. The global burden of cancer 2013. Jama Oncol. 2015;1:505\u201327.","journal-title":"Jama Oncol"},{"key":"4332_CR2","first-page":"e1433","volume":"6","author":"E Goodarzi","year":"2019","unstructured":"Goodarzi E, Beiranvand R, Mosavi-Jarrahi A, et al. Worldwide incidence and mortality of colorectal cancer and human development index (HDI): an ecological study. World Caner Res J. 2019;6:e1433.","journal-title":"World Caner Res J"},{"issue":"12","key":"4332_CR3","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","volume":"68","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019;68(12):2179\u201385.","journal-title":"Gut"},{"issue":"2","key":"4332_CR4","first-page":"89","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89\u2013103.","journal-title":"Prz Gastroenterol"},{"issue":"7","key":"4332_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S2468-1253(19)30147-5","volume":"4","author":"M Araghi","year":"2019","unstructured":"Araghi M, Soerjomataram I, Bardot A, et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019;4(7):511\u20138.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4332_CR6","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD. Cancer statistics. CA Cancer J Clin. 2020; 2020(70): 7\u201330.","DOI":"10.3322\/caac.21590"},{"key":"4332_CR7","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012, CA A cancer. J Clin. 2015;65:87\u2013108.","journal-title":"J Clin"},{"key":"4332_CR8","first-page":"290","volume":"66","author":"CE DeSantis","year":"2016","unstructured":"DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI, Jemal A. Cancer statistics for African Americans, 2016: progress and opportunities in reducing Racial disparities. CA Cancer J Clin. 2016;66:290\u2013308.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4332_CR9","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/ijc.26448","volume":"130","author":"AN Tavare","year":"2012","unstructured":"Tavare AN, Perry NJ, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer. 2012;130(6):1237\u201350. https:\/\/doi.org\/10.1002\/ijc.26448.","journal-title":"Int J Cancer"},{"issue":"4","key":"4332_CR10","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1016\/j.clcc.2020.05.005","volume":"19","author":"A BATRA","year":"2020","unstructured":"BATRA A, CHEUNG W KONGS. Eligibility of Real-World patients with stage II and III colon cancer for adjuvant chemotherapy Trials[J\/OL]. Clin Colorectal Cancer. 2020;19(4):e226\u201334. https:\/\/doi.org\/10.1016\/j.clcc.2020.05.005.","journal-title":"Clin Colorectal Cancer"},{"key":"4332_CR11","doi-asserted-by":"publisher","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. NEngl JMed. (2004) 350:2343\u201351. https:\/\/doi.org\/10.1056\/NEJMoa032709","DOI":"10.1056\/NEJMoa032709"},{"key":"4332_CR12","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/S0140-6736(07)61866-2","volume":"370","author":"R Gray","year":"2007","unstructured":"Gray R, Barnwell J, McConkey C, Hills RK, Williams NS. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007;370:2020. https:\/\/doi.org\/10.1016\/S0140-6736(07)61866-2.","journal-title":"Lancet"},{"key":"4332_CR13","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1200\/JCO.2008","volume":"27","author":"D Sargent","year":"2009","unstructured":"Sargent D, Sobrero A, Grothey A, O\u2019Connell MJ, Buyse M, Andre T, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2009;27:872\u20137. https:\/\/doi.org\/10.1200\/JCO.2008.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4332_CR14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1200\/JCO.21.02538","volume":"40","author":"NN Baxter","year":"2022","unstructured":"Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Lieu C, Mahmoud N, Morris AM, Ruiz-Garcia E, You YN, Meyerhardt JA. Adjuvant therapy for stage II colon cancer: ASCO guideline update. J Clin Oncology: Official J Am Soc Clin Oncol. 2022;40(8):892\u2013910. https:\/\/doi.org\/10.1200\/JCO.21.02538.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"4332_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ags3.12375","volume":"4","author":"E Shinto","year":"2020","unstructured":"Shinto E, Ike H, Hida J, Kobayashi H, Hashiguchi Y, Hase K, et al. Proposal of a modified subclassification system for stage III colorectal cancer: a multi-institutional retrospective analysis. Ann Gastroenterol Surg. 2020;4:667\u201375.","journal-title":"Ann Gastroenterol Surg"},{"key":"4332_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/bjs.1800239017","volume":"23","author":"WB Gabriel","year":"1935","unstructured":"Gabriel WB, Dukes C, Bussey HJR. Lymphatic spread in cancer of the rectum. Br J Surg. 1935;23:395\u2013413.","journal-title":"Br J Surg"},{"key":"4332_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3656-4","volume-title":"AJCC cancer staging manual","author":"FL Greene","year":"2002","unstructured":"Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 6th ed. New York: Springer-; 2002.","edition":"6"},{"key":"4332_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/SLA.0b013e31821ad8a2","volume":"255","author":"LL Tong","year":"2012","unstructured":"Tong LL, Gao P, Wang ZN, et al. Is the seventh edition of the UICC\/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer? Ann Surg. 2012;255:208\u201313.","journal-title":"Ann Surg"},{"issue":"8","key":"4332_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.21037\/atm-20-4728","volume":"9","author":"R Bai","year":"2021","unstructured":"Bai R, Tan Y, Li D, Yang M, Yu L, Yuan Y, Fang X. Development and validation of a novel prognostic nomogram including tumor deposits could better predict survival for colorectal cancer: a population-based study. Ann Transl Med. 2021;9(8):620. https:\/\/doi.org\/10.21037\/atm-20-4728. PMID: 33987318; PMCID: PMC8106036.","journal-title":"Ann Transl Med"},{"issue":"21","key":"4332_CR20","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.7150\/jca.27475","volume":"9","author":"S Basnet","year":"2018","unstructured":"Basnet S, Lou QF, Liu N, Rana R, Shah A, Khadka M, Warrier H, Sigdel S, Dhakal S, Devkota A, Mishra R, Sapkota G, Zheng L, Ge HY. Tumor deposit is an independent prognostic indicator in patients who underwent radical resection for colorectal cancer. J Cancer. 2018;9(21):3979\u201385. https:\/\/doi.org\/10.7150\/jca.27475. PMID: 30410602; PMCID: PMC6218780.","journal-title":"J Cancer"},{"issue":"1","key":"4332_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.soc.2013.09.009","volume":"23","author":"C Brezden-Masley","year":"2014","unstructured":"Brezden-Masley C, Polenz C. Current practices and challenges of adjuvant chemotherapy in patients with colorectal cancer. Surg Oncol Clin N Am. 2014;23(1):49\u201358. https:\/\/doi.org\/10.1016\/j.soc.2013.09.009.","journal-title":"Surg Oncol Clin N Am"},{"key":"4332_CR22","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/ijc.31168","volume":"42","author":"M Babaei","year":"2017","unstructured":"Babaei M, Balavarca Y, Jansen L, van Erning FN, van Eycken L, et al. Administration of adjuvant chemotherapy for stage II-III colon cancer patients: an European population-based study. Int J Cancer. 2017;42:1480\u20139. https:\/\/doi.org\/10.1002\/ijc.31168.","journal-title":"Int J Cancer"},{"key":"4332_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1245\/s10434-018-6484-8","volume":"25","author":"BD Babcock","year":"2018","unstructured":"Babcock BD, Aljehani MA, Jabo B, Choi AH, Morgan JW, Selleck MJ, et al. High-risk stage II colon cancer: not all risks are created equal. Ann SurgOncol. 2018;25:1\u20136. https:\/\/doi.org\/10.1245\/s10434-018-6484-8.","journal-title":"Ann SurgOncol"},{"key":"4332_CR24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.4143\/crt.2017.194","volume":"50","author":"DD KimMK, Won","year":"2017","unstructured":"KimMK, Won DD, Park SM, Kim T, Kim SR, Oh ST, et al. Effect of adjuvant chemotherapy on stage II colon cancer: analysis of Korean National data. Cancer Res Treat. 2017;50:1149\u201363. https:\/\/doi.org\/10.4143\/crt.2017.194.","journal-title":"Cancer Res Treat"},{"key":"4332_CR25","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.ejso.2015.07.019","volume":"41","author":"R Bernhoff","year":"2015","unstructured":"Bernhoff R, Martling A, Sjovall A, et al. Improved survival after an educational project on colon cancer management in the County of Stockholm\u2013A population based cohort study. Eur J Surg Oncol. 2015;41:1479\u201384.","journal-title":"Eur J Surg Oncol"},{"key":"4332_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1470-2045(14)71168-4","volume":"16","author":"CA Bertelsen","year":"2015","unstructured":"Bertelsen CA, Neuenschwander AU, Jansen JE, et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol. 2015;16:161\u20138.","journal-title":"Lancet Oncol"},{"key":"4332_CR27","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1007\/s00464-016-5270-6","volume":"31","author":"CL Deijen","year":"2017","unstructured":"Deijen CL, Vasmel JE, de Lange-de Klerk ESM, et al. Ten-year outcomes of a randomised trial of laparoscopic versus open surgery for colon cancer. Surg Endosc. 2017;31:2607\u201315.","journal-title":"Surg Endosc"},{"key":"4332_CR28","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","volume":"22","author":"AB Benson","year":"2004","unstructured":"Benson AB 3rd, Schrag D, Somerfield MR, et al. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. JCO. 2004;22:3408\u201319.","journal-title":"JCO"},{"key":"4332_CR29","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1634\/theoncologist.2013-0401","volume":"19","author":"G Srivastava","year":"2014","unstructured":"Srivastava G, Renfro LA, Behrens RJ, et al. Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients. Oncologist. 2014;19:492\u20137.","journal-title":"Oncologist"},{"key":"4332_CR30","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1001\/jama.294.21.2703","volume":"294","author":"JM Jessup","year":"2005","unstructured":"Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race\/ethnicity, age, and differentiation. JAMA. 2005;294:2703\u201311.","journal-title":"JAMA"},{"key":"4332_CR31","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1200\/JCO.2002.20.5.1192","volume":"20","author":"AL Potosky","year":"2002","unstructured":"Potosky AL, Harlan LC, Kaplan RS, et al. Age, sex, and Racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20:1192\u2013202.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4332_CR32","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/cncr.29129","volume":"121","author":"TJ Price","year":"2015","unstructured":"Price TJ, Beeke C, Ullah S, Padbury R, Maddern G, Roder D, Townsend AR, Moore J, Roy A, Tomita Y, Karapetis C. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? Cancer. 2015;121(6):830\u20135. https:\/\/doi.org\/10.1002\/cncr.29129. Epub 2014 Nov 6. PMID: 25377235.","journal-title":"Cancer"},{"issue":"17","key":"4332_CR33","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.3748\/wjg.v21.i17.5158","volume":"21","author":"JH Kim","year":"2015","unstructured":"Kim JH. Chemotherapy for colorectal cancer in the elderly. World J Gastroenterol. 2015;21(17):5158\u201366. https:\/\/doi.org\/10.3748\/wjg.v21.i17.5158. PMID: 25954089; PMCID: PMC4419056.","journal-title":"World J Gastroenterol"},{"key":"4332_CR34","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2010.34.3426","volume":"29","author":"ES O\u2019Connor","year":"2011","unstructured":"O\u2019Connor ES, Greenblatt DY, LoConte NK, et al. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol. 2011;29:3381\u20138.","journal-title":"J Clin Oncol"},{"key":"4332_CR35","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.clon.2016.09.001","volume":"29","author":"CM Booth","year":"2017","unstructured":"Booth CM, Nanji S, Wei X, et al. Adjuvant chemotherapy for stage II colon cancer: practice patterns and effectiveness in the general population. Clin Oncol. 2017;29:e29\u201338.","journal-title":"Clin Oncol"},{"key":"4332_CR36","first-page":"3277","volume":"122","author":"L Casadaban","year":"2016","unstructured":"Casadaban L, Rauscher G, Aklilu M, et al. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer. Cancer Am Cancer Soc. 2016;122:3277\u201387.","journal-title":"Cancer Am Cancer Soc"},{"key":"4332_CR37","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1200\/JCO.2010.33.7725","volume":"29","author":"H Ueno","year":"2011","unstructured":"Ueno H, Mochizuki H, Shirouzu K, et al. Actual status of distribution and prognostic impact of extramural discontinuous cancer spread in colorectal cancer. J Clin Oncol. 2011;29:2550\u20136.","journal-title":"J Clin Oncol"},{"key":"4332_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/SLA.0b013e31824b4839","volume":"255","author":"H Ueno","year":"2012","unstructured":"Ueno H, Mochizuki H, Shirouzu K, et al. Multicenter study for optimal categorization of extramural tumor deposits for colorectal cancer staging. Ann Surg. 2012;255:739\u201346.","journal-title":"Ann Surg"},{"key":"4332_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.amjsurg.2013.04.009","volume":"207","author":"H Ueno","year":"2014","unstructured":"Ueno H, Hashiguchi Y, Shimazaki H, et al. Peritumoral deposits as an adverse prognostic indicator of colorectal cancer. Am J Surg. 2014;207:70\u20137.","journal-title":"Am J Surg"},{"key":"4332_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/his.12936","volume":"69","author":"M Erin","year":"2016","unstructured":"Erin M, M LAA, Xianghua Y, Sheng-Zhong D, Lanjing Z. Prognostic value of tumour deposit and perineural invasion status in colorectal cancer patients: a SEER-based population study. Histopathology. 2016;69:230\u20138.","journal-title":"Histopathology"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04332-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04332-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04332-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T14:25:31Z","timestamp":1769437531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04332-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4332"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04332-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SEER database provides publicly available data for this study, which means that obtaining informed consent from ethical approval from an institutional review board is not necessary. We obtained access to the 1979\u20132019 SEER Research Data File by signing a Data-Use Agreement that outlines the terms and conditions for access. The SEER database provides publicly available data for this study, which means that obtaining informed consent from participants from an institutional review board is not necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and cosent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}